⚠️ New preprint ⚠️: Two new antibiotics are likely coming for gonorrhea 💊. How should we deploy them in the US to minimize drug resistance? @kroster.bsky.social @dhelekal.bsky.social Eva Rumpler @yhgrad.bsky.social [1/10] www.medrxiv.org/content/10.1...

New preprint. After years of increases, gonorrhea diagnosis rates dropped in the US in 2022 and 2023. While the news is promising, understanding WHY is key to sustaining progress. dash.harvard.edu/handle/1/427...

In our new paper in PLOS Neglected Tropical Diseases, we quantified the gap between expected and observed dengue cases in Brazil. We used an interrupted time series approach, incorporating predictions generated by machine learning models. With @kroster.bsky.social journals.plos.org/plosntds/art...

Now published in AJE: academic.oup.com/aje/advance-...

New preprint: Drug resistant gonorrhea is a big public health problem. Resistance to ceftriaxone, the last approved antibiotic, is spreading globally. When we first detect one of these very resistant isolates, how many undetected cases are there likely to be? www.medrxiv.org/content/10.1...